AKIN GUMP STRAUSS HAUER & FELD

Lobbying for UCB, INC. · Biopharmaceutical company

Filing 2nd Quarter - Report

Reporting period

2nd Quarter 2026

Apr 1 - June 30 · Posted Jul 20, 2026

Income

$80,000.00

What the client paid this registrant for the period.

Client based in

Georgia

Government bodies contacted 6

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Lobbying activity 1

Trade (domestic/foreign)

Issues related to global biopharmaceutical supply chains; Issues related to Section 232 investigations on pharmaceuticals.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.